Besides, the higher prevalence of anti-IFN-γ autoAbs among the Chinese COVID-19 patients compared with the Hispanic patients (21.4% vs. 9.1%) in our study supports the previous findings that anti-IFN-γ autoAbs-associated AOID was prevalent in the Asian population [3–9]. The gene discussed is IFNG; the disease is COVID-19.